(Q54483843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Kun Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Quan-Tong Deng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Ning Liao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Guo-Chun Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Yan-Hui Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Fang-Ping Xu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jian Zu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Xue-Rui Li

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

14 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

33-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-012-0507-z

13 February 2020

exact match

0 references

cites work

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor res

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Evaluation of prognostic and predictive value of microtubule associated protein tau in two independent cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Structure and novel exons of the human tau gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Repeat motifs of tau bind to the insides of microtubules in the absence of taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Microtubule Associated Protein (MAP)-Tau: a novel mediator of paclitaxel sensitivity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

BCIRG 001 molecular analysis: prognostic factors in node-positive breast cancer patients receiving adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Predictive markers of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0507-Z

Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments' armamentarium

21 January 2018

1 reference

12 December 2020

Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer

1 reference

12 December 2020

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome

1 reference

12 December 2020

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

12 December 2020

10.1007/S13277-012-0507-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22976542%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference